UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 08, 2022 |
INOGEN, INC.
(Exact name of Registrant as Specified in Its Charter)
Delaware | 001-36309 | 33-0989359 | ||
(State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||
|
|
|
|
|
301 Coromar Drive |
| |||
Goleta, California |
| 93117 | ||
(Address of Principal Executive Offices) |
| (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (805) 562-0500 |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
| Trading |
|
|
Common Stock, $0.001 par value |
| INGN |
| The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
Inogen, Inc. (the “Company”) held its 2022 annual meeting of stockholders on June 8, 2022 (the “Annual Meeting”). Of the 22,835,794 shares of the Company’s common stock outstanding as of the record date of April 11, 2022, 20,595,021 shares were represented at the Annual Meeting, either by proxy or by attending the meeting, constituting approximately 90.18% of the outstanding shares of common stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:
Nominee |
| Votes For |
| Votes Withheld |
| Broker Non-Votes |
Kevin King |
| 19,195,244 |
| 114,388 |
| 1,285,389 |
Mary Kay Ladone |
| 19,195,296 |
| 114,336 |
| 1,285,389 |
Nabil Shabshab |
| 14,647,832 |
| 4,661,800 |
| 1,285,389 |
Votes For |
| Votes Against |
| Abstentions |
| Broker Non-Votes |
20,562,878 |
| 8,721 |
| 23,422 |
| — |
Votes For |
| Votes Against |
| Abstentions |
| Broker Non-Votes |
18,392,222 |
| 885,879 |
| 31,531 |
| 1,285,389 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
| INOGEN, INC. |
|
|
|
|
Date: | June 13, 2022 | By: | /s/ Kristin Caltrider |
|
|
| Kristin Caltrider |